CS logo
small CS logo
Berner Augenklinik am Lindenhofspital

Bern, Switzerland
Eye care center in Bern
Bremgartenstrasse 119, 3012 Bern

About Berner Augenklinik am Lindenhofspital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Berner Augenklinik am Lindenhofspital


During the past decade, Berner Augenklinik am Lindenhofspital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Berner Augenklinik am Lindenhofspital" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "medignition AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Berner Augenklinik am Lindenhofspital


According to Clinical.Site data, the most researched conditions in "Berner Augenklinik am Lindenhofspital" are "Neovascular Age-Related Macular Degeneration" (1 trials), "Retinal Detachment" (1 trials) and "Wet Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Berner Augenklinik am Lindenhofspital" in a lesser frequency.

Clinical Trials Intervention Types at Berner Augenklinik am Lindenhofspital


Most popular intervention types in "Berner Augenklinik am Lindenhofspital" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (1 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "Brolucizumab" (1 trials) and "ILM (inner limiting membrane) peeling" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Berner Augenklinik am Lindenhofspital


The vast majority of trials in "Berner Augenklinik am Lindenhofspital" are 3 trials for "All" genders.

Clinical Trials Status at Berner Augenklinik am Lindenhofspital


Currently, there are NaN active trials in "Berner Augenklinik am Lindenhofspital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were undefined completed trials in Berner Augenklinik am Lindenhofspital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Berner Augenklinik am Lindenhofspital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".